[The CUP syndrome--malignant disease with unknown primary tumor. Part 3: Metastatic site--tumor markers].
Multiple axillary-infraclavicular lymph node metastasis from malignant rhabdoid tumor of unknown primary site.
NCCN Clinical Practice Guidelines Occult primary.
Ettinger DS, Agulnik M, Cates JM, Cristea M, Denlinger CS, Eaton KD, Fidias PM, Gierada D, Gockerman JP, Handorf CR, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Shulman LN, Smerage JB, Varadhachary GR, Zager JS, Zhen WK; National Comprehensive Cancer Network.
J Natl Compr Canc Netw. 2011 Dec;9(12):1358-95. doi: 10.6004/jnccn.2011.0117.
A practical diagnostic approach to hepatic masses.
Vyas M, Jain D.
Indian J Pathol Microbiol. 2018 Jan-Mar;61(1):2-17. doi: 10.4103/IJPM.IJPM_578_17.
Carcinoma of unknown primary (CUP): an update for histopathologists.
Beauchamp K, Moran B, O'Brien T, Brennan D, Crown J, Sheahan K, Cotter MB.
Cancer Metastasis Rev. 2023 Dec;42(4):1189-1200. doi: 10.1007/s10555-023-10101-6. Epub 2023 Jul 3.
Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
Li X, Shao Y, Sheng L, Zhu J, Wang Z, Guo K, Sun L.
Cancer Med. 2021 Feb;10(3):974-988. doi: 10.1002/cam4.3684. Epub 2021 Jan 6.
Cancer of unknown primary site.
Pavlidis N, Pentheroudakis G.
Lancet. 2012 Apr 14;379(9824):1428-35. doi: 10.1016/S0140-6736(11)61178-1. Epub 2012 Mar 12.
Melanoma of unknown primary: New perspectives for an old story.
Boussios S, Rassy E, Samartzis E, Moschetta M, Sheriff M, Pérez-Fidalgo JA, Pavlidis N.
Crit Rev Oncol Hematol. 2021 Feb;158:103208. doi: 10.1016/j.critrevonc.2020.103208. Epub 2020 Dec 28.
Familial cancer of unknown primary.
Rassy E, Kattan J, Pavlidis N.
Int J Clin Oncol. 2019 Oct;24(10):1328-1331. doi: 10.1007/s10147-019-01491-1. Epub 2019 Jun 15.
Diagnostic Approaches to Neuroendocrine Neoplasms of Unknown Primary Site.
Berner AM, Pipinikas C, Ryan A, Dibra H, Moghul I, Webster A, Luong TV, Thirlwell C.
Neuroendocrinology. 2020;110(7-8):563-573. doi: 10.1159/000504370. Epub 2019 Oct 28.
Immunohistochemistry, carcinomas of unknown primary, and incidence rates.
Stelow EB, Yaziji H.
Semin Diagn Pathol. 2018 Mar;35(2):143-152. doi: 10.1053/j.semdp.2017.11.012. Epub 2017 Nov 23.
Carcinoma of unknown primary site.
Greco FA, Hainsworth JD.
Ann Oncol. 1990;1(2):98-9. doi: 10.1093/oxfordjournals.annonc.a057702.
